NL-OMON35628撤回不适用
The ACER-study - the effects of galantamine on the variability and stability of walking among patients with Alzheimer's disease. - The ACER-study
Slotervaartziekenhuis0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patients will be included for the present study when they are (a) aged 65 years or older; (b) diagnosed with mild to moderate Alzheimer's disease (according to the criteria of the DSM-IV and the NINCDS-ADRDA); and (c) able to walk for at least 160 meter without using any assistive device.
排除标准
- •Patients will be excluded from the present study when they (a) have had any treatment with acetylcholine esterase inhibitors during the three months before inclusion; (b) have any mobility problems due to (lateral) neurological or orthopedic disorders with function limitations of one or both legs; (c) have severe visual impairments; or (d) are unable to understand and follow simple verbal instructions.
研究者
相似试验
进行中（未招募）
不适用
The ACER-study - examining the effects of galantamine on gait.EUCTR2011-006011-62-NLSlotervaart Hospital
已完成
2 期
Effect of Galantamine on Smoking AbstinenceNicotine AddictionNCT01548638University of Pennsylvania13
已完成
不适用
The effects of galantamine administration on brain network topology in patients with Alzheimer's disease (AD): A possible new biomarker for pharmacotherapy of ADmild to moderate Alzhiemer's diseaseJPRN-UMIN000018749atinal Center of Neurology and Psychiatry9
招募中
2 期
Evaluation the Effect of Adding Galantamine to Second Generation AntipsychoticsSchizophreniaIRCT20181117041682N2Ahvaz University of Medical Sciences28
已完成
不适用
The effects of galantamine on brain network topology in patients with Alzheimer's diseasemild to moderate Alzhiemer's diseaseJPRN-jRCTs031180337Hanakawa Takashi9